Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.

Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA.

Influenza Other Respir Viruses. 2014 Nov;8(6):628-35. doi: 10.1111/irv.12285. Epub 2014 Sep 12.

2.

Influenza vaccination accelerates recovery of ferrets from lymphopenia.

Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, Wilson JR, Donis RO, Katz JM, York IA.

PLoS One. 2014 Jun 26;9(6):e100926. doi: 10.1371/journal.pone.0100926. eCollection 2014.

3.

Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.

Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR.

Eur J Pharm Biopharm. 2012 Jun;81(2):239-47. doi: 10.1016/j.ejpb.2012.03.010. Epub 2012 Apr 3.

4.

In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity.

Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, Cox NJ, Paulson JC, Donis RO.

Virology. 2012 Jan 5;422(1):105-13. doi: 10.1016/j.virol.2011.10.006. Epub 2011 Nov 5. Erratum in: Virology. 2012 Mar 15;424(2):154.

5.

Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.

Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO.

Clin Vaccine Immunol. 2011 Dec;18(12):2010-7. doi: 10.1128/CVI.05206-11. Epub 2011 Oct 26.

6.

The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins.

Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO.

J Virol. 2011 Jul;85(14):7048-58. doi: 10.1128/JVI.00417-11. Epub 2011 May 18.

7.

The development of vaccine viruses against pandemic A(H1N1) influenza.

Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO.

Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.

PMID:
21199698
8.

Flexible label-free quantitative assay for antibodies to influenza virus hemagglutinins.

Carney PJ, Lipatov AS, Monto AS, Donis RO, Stevens J.

Clin Vaccine Immunol. 2010 Sep;17(9):1407-16. doi: 10.1128/CVI.00509-09. Epub 2010 Jul 21.

9.

Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.

Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall JC, Donis RO, Prausnitz MR, Compans RW, Kang SM.

Clin Vaccine Immunol. 2010 Sep;17(9):1381-9. doi: 10.1128/CVI.00100-10. Epub 2010 Jul 14.

10.

Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.

Song JM, Hossain J, Yoo DG, Lipatov AS, Davis CT, Quan FS, Chen LM, Hogan RJ, Donis RO, Compans RW, Kang SM.

Virology. 2010 Sep 15;405(1):165-75. doi: 10.1016/j.virol.2010.05.034. Epub 2010 Jun 26.

11.

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, Chen LM, Donis RO, Compans RW.

PLoS One. 2009;4(3):e4667. doi: 10.1371/journal.pone.0004667. Epub 2009 Mar 2.

12.

Pathogenesis of H5N1 influenza virus infections in mice and ferret models differs according to respiratory tract or digestive system exposure.

Lipatov AS, Kwon YK, Pantin-Jackwood MJ, Swayne DE.

J Infect Dis. 2009 Mar 1;199(5):717-25. doi: 10.1086/596740.

PMID:
19210164
13.

Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.

Yen HL, Aldridge JR, Boon AC, Ilyushina NA, Salomon R, Hulse-Post DJ, Marjuki H, Franks J, Boltz DA, Bush D, Lipatov AS, Webby RJ, Rehg JE, Webster RG.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):286-91. doi: 10.1073/pnas.0811052106. Epub 2008 Dec 30.

14.

Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus.

Kwon YK, Lipatov AS, Swayne DE.

Vet Pathol. 2009 Jan;46(1):138-41. doi: 10.1354/vp.46-1-138.

PMID:
19112127
15.

Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses.

Lipatov AS, Kwon YK, Sarmento LV, Lager KM, Spackman E, Suarez DL, Swayne DE.

PLoS Pathog. 2008 Jul 11;4(7):e1000102. doi: 10.1371/journal.ppat.1000102.

16.

The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.

Lipatov AS, Yen HL, Salomon R, Ozaki H, Hoffmann E, Webster RG.

Arch Virol. 2008;153(3):427-34. Epub 2007 Dec 4.

PMID:
18058063
17.

Diversity of highly pathogenic avian influenza H5N1 viruses that caused epizootic in Western Siberia in 2005.

Evseenko VA, Zaykovskaya AV, Ternovoi VA, Durimanov AG, Zolotykh SI, Rassadkin YN, Lipatov AS, Webster RG, Shestopalov AM, Netesov SV, Drosdov IG, Onishchenko GG.

Dokl Biol Sci. 2007 May-Jun;414:226-30. No abstract available.

PMID:
17668629
18.

Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006.

Lipatov AS, Evseenko VA, Yen HL, Zaykovskaya AV, Durimanov AG, Zolotykh SI, Netesov SV, Drozdov IG, Onishchenko GG, Webster RG, Shestopalov AM.

Emerg Infect Dis. 2007 Apr;13(4):539-46.

19.

Inefficient transmission of H5N1 influenza viruses in a ferret contact model.

Yen HL, Lipatov AS, Ilyushina NA, Govorkova EA, Franks J, Yilmaz N, Douglas A, Hay A, Krauss S, Rehg JE, Hoffmann E, Webster RG.

J Virol. 2007 Jul;81(13):6890-8. Epub 2007 Apr 25.

20.

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.

Lipatov AS, Hoffmann E, Salomon R, Yen HL, Webster RG.

J Infect Dis. 2006 Oct 15;194(8):1040-3. Epub 2006 Sep 12.

PMID:
16991078
21.

Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.

Hoffmann E, Lipatov AS, Webby RJ, Govorkova EA, Webster RG.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12915-20. Epub 2005 Aug 23.

22.

Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses.

Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, Krauss S, Perez DR, Doherty PC, Webster RG, Sangster MY.

J Gen Virol. 2005 Apr;86(Pt 4):1121-30.

PMID:
15784906
23.

Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.

Lipatov AS, Webby RJ, Govorkova EA, Krauss S, Webster RG.

J Infect Dis. 2005 Apr 15;191(8):1216-20. Epub 2005 Mar 14.

PMID:
15776365
24.

Highly lethal H5N1 influenza virus in asia: Genesis and options for control.

Lipatov AS, Webster RG.

Discov Med. 2004 Dec;4(24):378-83.

25.

Influenza: emergence and control.

Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG.

J Virol. 2004 Sep;78(17):8951-9. Review. No abstract available.

26.

H5N1 influenza: a protean pandemic threat.

Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, Chan KH, Sturm-Ramirez KM, Cheung CL, Leung YH, Yuen KY, Webster RG, Peiris JS.

Proc Natl Acad Sci U S A. 2004 May 25;101(21):8156-61. Epub 2004 May 17.

27.

Influenza H5 virus escape mutants: immune protection and antibody production in mice.

Smirnov YA, Gitelman AK, Govorkova EA, Lipatov AS, Kaverin NV.

Virus Res. 2004 Feb;99(2):205-8.

PMID:
14749187
28.
29.

[Antigenic structure of influenza A virus subtype H5 hemagglutinin: mechanism of acquiring stability to monoclonal antibodies in escape-mutants].

Il'iushina NA, Rudneva IA, Varich NL, Lipatov AS, Webster RG, Kaverin NV.

Mol Gen Mikrobiol Virusol. 2003;(1):40-5. Russian.

PMID:
12656046
30.

Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001.

Lipatov AS, Krauss S, Guan Y, Peiris M, Rehg JE, Perez DR, Webster RG.

J Virol. 2003 Mar;77(6):3816-23.

31.

Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.

Kaverin NV, Rudneva IA, Ilyushina NA, Varich NL, Lipatov AS, Smirnov YA, Govorkova EA, Gitelman AK, Lvov DK, Webster RG.

J Gen Virol. 2002 Oct;83(Pt 10):2497-505.

PMID:
12237433
32.

Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.

Guan Y, Peiris JS, Lipatov AS, Ellis TM, Dyrting KC, Krauss S, Zhang LJ, Webster RG, Shortridge KF.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8950-5. Epub 2002 Jun 19.

33.

Fusion of a single influenza virion particle with BLM.

Maksaev GI, Samsonov AV, Lipatov AS, Bychenko AB, Frolov VA.

Membr Cell Biol. 2000;14(3):397-411.

PMID:
11368500
35.

Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host.

Smirnov YA, Lipatov AS, Van Beek R, Gitelman AK, Osterhaus AD, Claas EC.

Acta Virol. 2000 Feb;44(1):1-8.

PMID:
10989685
36.

Cross-protection and reassortment studies with avian H2 influenza viruses.

Kaverin NV, Smirnov YA, Govorkova EA, Rudneva IA, Gitelman AK, Lipatov AS, Varich NL, Yamnikova SS, Makarova NV, Webster RG, Lvov DK.

Arch Virol. 2000;145(6):1059-66.

PMID:
10948982
37.

An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.

Smirnov YA, Lipatov AS, Gitelman AK, Okuno Y, Van Beek R, Osterhaus AD, Claas EC.

Acta Virol. 1999 Aug;43(4):237-44.

PMID:
10749369
38.

[A common antigenic epitope in influenza A virus (H1, H2, H5, H6) hemagglutinin].

Smirnov IuA, Lipatov AS, Okuno I, Gitel'man AK.

Vopr Virusol. 1999 May-Jun;44(3):111-5. Russian.

PMID:
10392433
39.
41.
42.

[Changes in biological and physico-chemical properties of avian influenza virus A hemagglutinin H2 during adaptation to a new host].

Lipatov AS, Gitel'man AK, Govorkova EA, Smirnov IuA.

Vopr Virusol. 1995 Sep-Oct;40(5):208-11. Russian.

PMID:
8659174

Supplemental Content

Loading ...
Support Center